Ogkologos

4398 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

FDA Approves Alpelisib for PIK3CA-Related Overgrowth Spectrum

Ogkologos - 13 Απριλίου, 2022

NGS Is Effective in Identifying Actionable Genetic Alterations for Investigational Targeted...

Ogkologos - 13 Απριλίου, 2022

How Cancer Survivors Can Overcome Common Challenges of Exercise After Treatment

Ogkologos - 12 Απριλίου, 2022

FDA Approves a Fixed-Dose Combination of Nivolumab and Relatlimab for Unresectable...

Ogkologos - 12 Απριλίου, 2022

The new home for your research tools

Ogkologos - 11 Απριλίου, 2022

Increased Efficacy of Pembrolizumab or Pembrolizumab-Chemotherapy with Increasing PD-L1 Expression in...

Ogkologos - 11 Απριλίου, 2022

The award-winning team transforming breast cancer treatment

Ogkologos - 10 Απριλίου, 2022

Triple negative breast cancer drug given initial ‘no’ for NHS in...

Ogkologos - 8 Απριλίου, 2022

Stem cell research: meet the scientist growing ‘mini guts’ in her...

Ogkologos - 8 Απριλίου, 2022

Treatment with Nivolumab and Low-Dose Ipilimumab is Effective and Tolerable in...

Ogkologos - 8 Απριλίου, 2022

1...206207208...440 Σελίδα 207 από 440

MOST POPULAR

Zanubrutinib’s Approval Improves Targeted Treatment for CLL

27 Ιανουαρίου, 2023

GreaterGood Charities Provides Supplies and Support to People and Pets After...

17 Δεκεμβρίου, 2021

EMA Recommends Extension of Indications for Sugemalimab

28 Οκτωβρίου, 2025

Enhertu May Be Preferred Therapy for Some Metastatic Breast Cancers

19 Οκτωβρίου, 2021

Φόρτωση περισσοτέρων

FDA Approves Alpelisib for PIK3CA-Related Overgrowth Spectrum

NGS Is Effective in Identifying Actionable Genetic Alterations for Investigational Targeted...

How Cancer Survivors Can Overcome Common Challenges of Exercise After Treatment

FDA Approves a Fixed-Dose Combination of Nivolumab and Relatlimab for Unresectable...

The new home for your research tools

Increased Efficacy of Pembrolizumab or Pembrolizumab-Chemotherapy with Increasing PD-L1 Expression in...

The award-winning team transforming breast cancer treatment

Triple negative breast cancer drug given initial ‘no’ for NHS in...

Stem cell research: meet the scientist growing ‘mini guts’ in her...

Treatment with Nivolumab and Low-Dose Ipilimumab is Effective and Tolerable in...

MOST POPULAR

Zanubrutinib’s Approval Improves Targeted Treatment for CLL

GreaterGood Charities Provides Supplies and Support to People and Pets After...

EMA Recommends Extension of Indications for Sugemalimab

Enhertu May Be Preferred Therapy for Some Metastatic Breast Cancers

HOT NEWS

Mobile Care Center Brings Breast Cancer Treatment to Amish and Mennonite...

FDA Approves Mirdametinib for Adult and Paediatric Patients with NF1 Who...

Opinion: ‘UK cancer research could be set back years by COVID-19. We must act now’

Opinion: ‘The UK must be more ambitious than just clearing the...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ